Recap: AbCellera Biologics Q4 Earnings

AbCellera Biologics ABCL reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

AbCellera Biologics missed estimated earnings by 30.77%, reporting an EPS of $-0.17 versus an estimate of $-0.13.

Revenue was down $12.37 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 6.09% increase in the share price the next day.

Here's a look at AbCellera Biologics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.13	-0.13	-0.14	0
EPS Actual	-0.10	-0.11	-0.14	-0.1
Revenue Estimate	11.90M	12.37M	12.11M	50.80M
Revenue Actual	6.60M	10.06M	12.19M	21.55M

To track all earnings releases for AbCellera Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar